Other Clinical Trial - Study With Idebenone in Patients With Chronic

Updated 06/21/2024

Status Withdrawn

Clinical Trial Summary

The objective of the study is to determine whether administration of idebenone can shorten the time to improvement of visual acuity in patients with chronic vision loss due to LHON.

Clinical Trial Description

n/a

Study Design

N/A

Related Conditions & MeSH terms

Leber's Hereditary Optic Neuropathy
Optic Atrophy, Hereditary, Leber
Optic Nerve Diseases

Clinical Trial Details

NCT number	NCT01495715
Study type	Interventional
Source	Santhera Pharmaceuticals
Contact
Status	Withdrawn
Phase	Phase 3

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01421381` - RHODOS Follow-up Single-visit Study	N/A
	Completed	`NCT00747487` - Study to Assess Efficacy,Safety and Tolerability of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy	Phase 2
	Completed	`NCT04909398` - Pupil Dynamics and Color Vision for the Detection of Eye Diseases	N/A
	Completed	`NCT02693119` - A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy	Phase 2
	Active, not recruiting	`NCT02161380` - Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy	Phase 1
	No longer available	`NCT02300753` - Emergency Administration of EPI-743 to a Single Patient With Leber's Hereditary Optic Neuropathy [LHON]	N/A
	No longer available	`NCT04381091` - Expanded Access Program for Idebenone in Patients With Leber's Hereditary Optic Neuropathy Who Completed the LEROS Study